Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 590

1.

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Kannel WB, Castelli WP, Gordon T, McNamara PM.

Ann Intern Med. 1971 Jan;74(1):1-12. No abstract available.

PMID:
5539274
2.

The coronary profile: 12-year follow-up in the Framingham study.

Kannel WB, Castelli WP, McNamara PM.

J Occup Med. 1967 Dec;9(12):611-9. No abstract available.

PMID:
6065137
3.

Blood pressure and risk of coronary heart disease: the Framingham study.

Kannel WB, Schwartz MJ, McNamara PM.

Dis Chest. 1969 Jul;56(1):43-52. No abstract available.

PMID:
5789839
4.

Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

Kannel WB, Gordon T, Schwartz MJ.

Am J Cardiol. 1971 Apr;27(4):335-46. No abstract available.

PMID:
5572576
5.

The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study.

Kannel WB.

G Ital Cardiol. 1974;4(1):123-37. No abstract available.

PMID:
4824624
6.

Physical activity at work, lipopproteins and the incidence of angina pectoris, myocardial infarction and death due to ischemic heart disease.

Manelis G, Eschchar J, Altman S, Modan M, Brunner D.

Isr J Med Sci. 1969 Jul-Aug;5(4):786-90. No abstract available.

PMID:
5820519
7.

Physical activity, lipoproteins and ischemic heart disease.

Brunner D, Manelis G, Altman S.

Pathol Microbiol (Basel). 1967;30(5):648-52. No abstract available.

PMID:
5585905
8.
9.

Coronary heart disease in the Western Collaborative Group Study. A follow-up experience of 4 and one-half years.

Rosenman RH, Friedman M, Straus R, Jenkins CD, Zyzanski SJ, Wurm M.

J Chronic Dis. 1970 Sep;23(3):173-90. No abstract available.

PMID:
5472388
10.

[Arteriosclerosis--nicotinic acid therapy. 1. Risk factors in myocardial infarct].

Tibblin G, Wilhelmsen L.

Lakartidningen. 1971 Apr 7;68(15):1738-43. Swedish. No abstract available.

PMID:
5577243
11.

Epidemiologic assessment of angina before and after myocardial infarction: The Framingham study.

Brand FN, Larson M, Friedman LM, Kannel WB, Castelli WP.

Am Heart J. 1996 Jul;132(1 Pt 1):174-8.

PMID:
8701860
12.
13.

The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study.

Abu-Zeid HA, Chapman JM.

J Chronic Dis. 1976 Jun;29(6):395-403. No abstract available.

PMID:
932168
14.

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.

Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H.

Circulation. 1999 Jun 8;99(22):2858-60.

15.
16.

The Framingham study of coronary disease in women.

Kannel WB, Castelli WP.

Med Times. 1972 May;100(5):173-5 passim. No abstract available.

PMID:
4338292
17.

[Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].

Orbetsov G, Orbetsova V, Dakovska L.

Vutr Boles. 1984;23(5):100-6. Bulgarian. No abstract available.

PMID:
6523839
18.
19.

[Epidemiology of coronary disease in women].

Muñiz J, Juane R, Beiras AC.

Rev Esp Cardiol. 1994;47 Suppl 3:6-12. Spanish. No abstract available.

PMID:
7816982
20.

Coronary heart disease in seven countries. IX. The Greek islands of Crete and Corfu.

Aravanis C, Corcondilas A, Dontas AS, Lekos D, Keys A.

Circulation. 1970 Apr;41(4 Suppl):I88-100. No abstract available.

PMID:
5442787

Supplemental Content

Support Center